Clinical trials: Immunosenescence

Covid19, Non-specific Effects of Vaccines

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

• Completed
• Age: 65 to 110 years
• Phase 3
• Vaccines
• Injection or infusion
• Results posted

Background: The virus SARS-CoV-2 has spread rapidly throughout the world. Seniors are at high risk of severe COVID-19 when infected.

Conditions

Covid19, Non-specific Effects of Vaccines, Heterologous Immunity, Morbidity

Trial name

NCT04542330

Testing

BCG-Denmark, Saline

Where

Denmark

Volunteers

1,700 people, healthy volunteers welcome

Sponsor

Bandim Health Project